Treating Cancer -- The Path Ahead
Oct 21, 2019
Max N. Wallace, CEO Accelerate Brain Cancer Cure
Treating Cancer -- The Path Ahead

President and CEO of ABC2, a venture philanthropy organization focused on developing new treatments for brain cancer. Mr. Wallace helped found the first venture-funded biotech company in NC -- Sphinx Biotechnologies in 1984. He also helped found a number of local companies including Trimeris, SARCO, Cogent Neuroscience and Humacyte.

A former member of Duke University Counsel's Office, former legal counsel for Duke Medical Center, member of the founding team for Duke Management Company, the University's asset management company. Former private practice attorney.